Skip to main content

Goldman Sachs & Co. LLC's Form 4 filing

T2 Biosystems, Inc. (TTOO) · filed Aug 3, 2021

Accession no.
0000899243-21-031362
Filed
Aug 3, 2021, 6:41 PM ET
Trade date
Mar 24-May 20, 2020
Filing delay
497 daysLate
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 30 non-derivative transactions. Open-market purchases total $29.8K. Open-market sales total $25.7K. It was filed 497 days after the trade, past the 2-business-day deadline.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Goldman Sachs & Co. LLCCIK 000076999310% Owner
Goldman Sachs Group IncCIK 000088698210% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Mar 24, 2020Common StockPPurchaseAcquired+500$0.378+$1894,196,956IndirectDuplicate filing
Mar 24, 2020Common StockSSaleDisposed−500$0.378−$1894,196,456IndirectDuplicate filing
Mar 25, 2020Common StockPPurchaseAcquired+600$0.9279+$556.744,197,056IndirectDuplicate filing
Mar 25, 2020Common StockSSaleDisposed−600$0.9279−$556.744,196,456IndirectDuplicate filing
Apr 9, 2020Common StockPPurchaseAcquired+1,000$0.49+$4904,197,456IndirectDuplicate filing
Apr 9, 2020Common StockSSaleDisposed−1,000$0.49−$4904,196,456IndirectDuplicate filing
May 6, 2020Common StockSSaleDisposed−2,655$0.52−$1,380.64,193,801IndirectDuplicate filing
May 6, 2020Common StockSSaleDisposed−1,000$0.521−$5214,192,801IndirectDuplicate filing
May 6, 2020Common StockSSaleDisposed−1,000$0.526−$5264,191,801IndirectDuplicate filing
May 6, 2020Common StockSSaleDisposed−500$0.528−$2644,191,301IndirectDuplicate filing
May 6, 2020Common StockSSaleDisposed−50$0.53−$26.54,191,251IndirectDuplicate filing
May 6, 2020Common StockSSaleDisposed−500$0.5318−$265.94,190,751IndirectDuplicate filing
May 6, 2020Common StockSSaleDisposed−100$0.5325−$53.254,190,651IndirectDuplicate filing
May 6, 2020Common StockSSaleDisposed−6,256$0.54−$3,378.244,184,395IndirectDuplicate filing
May 6, 2020Common StockSSaleDisposed−100$0.55−$554,184,295IndirectDuplicate filing
May 6, 2020Common StockSSaleDisposed−939$0.5503−$516.734,183,356IndirectDuplicate filing
May 6, 2020Common StockPPurchaseAcquired+26,200$0.5517+$14,454.544,209,556IndirectDuplicate filing
May 6, 2020Common StockSSaleDisposed−10,100$0.57−$5,7574,199,456IndirectDuplicate filing
May 6, 2020Common StockSSaleDisposed−2,000$0.5701−$1,140.24,197,456IndirectDuplicate filing
May 6, 2020Common StockSSaleDisposed−1,000$0.5702−$570.24,196,456IndirectDuplicate filing
May 12, 2020Common StockPPurchaseAcquired+2,500$0.546+$1,3654,198,956IndirectDuplicate filing
May 12, 2020Common StockSSaleDisposed−2,500$0.546−$1,3654,196,456IndirectDuplicate filing
May 19, 2020Common StockSSaleDisposed−200$0.8314−$166.284,196,256IndirectDuplicate filing
May 19, 2020Common StockSSaleDisposed−3,235$0.8318−$2,690.874,193,021IndirectDuplicate filing
May 19, 2020Common StockSSaleDisposed−2,031$0.8325−$1,690.814,190,990IndirectDuplicate filing
May 19, 2020Common StockSSaleDisposed−2,031$0.8326−$1,691.014,188,959IndirectDuplicate filing
May 19, 2020Common StockPPurchaseAcquired+10,328$0.8329+$8,602.194,199,287IndirectDuplicate filing
May 19, 2020Common StockSSaleDisposed−800$0.8345−$667.64,198,487IndirectDuplicate filing
May 19, 2020Common StockSSaleDisposed−2,031$0.8347−$1,695.284,196,456IndirectDuplicate filing
May 20, 2020Common StockPPurchaseAcquired+5,126$0.803+$4,116.184,201,582IndirectDuplicate filing

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Remarks

Balance of trades included in attached schedule. (See Exhibit 99.1)

Read the full filing on SEC EDGAR (opens in a new tab)